Agilent Technologies, Inc. (NYSE:A) Position Reduced by Corebridge Financial Inc.

Corebridge Financial Inc. reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 68,032 shares of the medical research company’s stock after selling 4,418 shares during the period. Corebridge Financial Inc.’s holdings in Agilent Technologies were worth $9,139,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Madison Investment Advisors LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $94,051,000. FMR LLC raised its holdings in shares of Agilent Technologies by 62.2% during the third quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock valued at $191,193,000 after acquiring an additional 493,947 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $48,172,000. Worldquant Millennium Advisors LLC acquired a new position in Agilent Technologies in the 3rd quarter worth approximately $49,449,000. Finally, Van ECK Associates Corp grew its position in Agilent Technologies by 8.7% during the 4th quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after purchasing an additional 258,358 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

NYSE A opened at $119.04 on Friday. The firm has a market cap of $33.94 billion, a P/E ratio of 27.37, a price-to-earnings-growth ratio of 3.38 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The stock’s 50-day moving average is $134.91 and its two-hundred day moving average is $136.80. Agilent Technologies, Inc. has a fifty-two week low of $117.17 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.83%. Agilent Technologies’s payout ratio is 22.76%.

Wall Street Analyst Weigh In

A has been the subject of a number of research analyst reports. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. Bank of America lowered their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Finally, Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $150.83.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.